Taillieu E, De Meyere C, Nuytens F, Verslype C, D'Hondt M. Laparoscopic liver resection for colorectal liver metastases — short- and long-term outcomes: A systematic review. World J Gastrointest Oncol 2021; 13(7): 732-757 [PMID: 34322201 DOI: 10.4251/wjgo.v13.i7.732]
Corresponding Author of This Article
Mathieu D'Hondt, MD, Doctor, Department of Digestive and Hepatobiliary/Pancreatic Surgery, AZ Groeninge, President Kennedylaan 4, Kortrijk 8500, Belgium. mathieudhondt2000@yahoo.com
Research Domain of This Article
Surgery
Article-Type of This Article
Systematic Reviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 732-757 Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.732
Laparoscopic liver resection for colorectal liver metastases — short- and long-term outcomes: A systematic review
Emily Taillieu, Celine De Meyere, Frederiek Nuytens, Chris Verslype, Mathieu D'Hondt
Emily Taillieu, Celine De Meyere, Frederiek Nuytens, Mathieu D'Hondt, Department of Digestive and Hepatobiliary/Pancreatic Surgery, AZ Groeninge, Kortrijk 8500, Belgium
Chris Verslype, Department of Gastroenterology and Hepatology, KU Leuven, Leuven 3000, Belgium
Author contributions: Taillieu E Performed the research, acquired the data, analyzed the data, wrote the paper; De Meyere C and Nuytens F supervised the paper; Verslype C and D’Hondt M designed the research, supervised the paper.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mathieu D'Hondt, MD, Doctor, Department of Digestive and Hepatobiliary/Pancreatic Surgery, AZ Groeninge, President Kennedylaan 4, Kortrijk 8500, Belgium. mathieudhondt2000@yahoo.com
Received: January 4, 2021 Peer-review started: January 4, 2021 First decision: May 3, 2021 Revised: May 16, 2021 Accepted: June 25, 2021 Article in press: June 25, 2021 Published online: July 15, 2021
ARTICLE HIGHLIGHTS
Research background
Laparoscopic liver resection (LLR) for colorectal liver metastases (CRLM) has become the gold standard in specialized centers and for well-selected patients and procedures.
Research motivation
Little is known concerning patient-related and peri-operative factors that could play a role in survival outcomes associated with LLR for CRLM.
Research objectives
The main objective was to provide an extensive summary of reported outcomes and prognostic factors associated with LLR for CRLM.
Research methods
A systematic review was performed in PubMed, EMBASE, Web of Science and the Cochrane Library, after which thorough screening was performed and data was extracted for qualitative analysis.
Research results
Qualitative analysis of 77 full-text publications shows that LLR for CRLM is safe, feasible and provides oncological efficiency. This is true for more complex laparoscopic procedures as well. Results on prognostic factors affecting long-term outcomes for LLR for CRLM are scarce.
Research conclusions
Besides short-term benefits, satisfactory oncological efficiency is reported for LLR for CRLM.
Research perspectives
Little is still known about prognostic factors affecting long-term outcomes of LLR for CRLM, and future prospective multicenter randomized controlled trials are needed to provide robust evidence.
